These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2416886)

  • 1. Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.
    Cramer H; Schaudt D; Rissler K; Strubel D; Warter JM; Kuntzmann F
    J Neurol; 1985; 232(6):346-51. PubMed ID: 2416886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive substance P and somatostatin in the cerebrospinal fluid of senile parkinsonian patients.
    Cramer H; Rissler K; Rösler N; Strubel D; Schaudt D; Kuntzmann F
    Eur Neurol; 1989; 29(1):1-5. PubMed ID: 2468498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease.
    Rissler K; Cramer H; Schaudt D; Strubel D; Gattaz WF
    Neurosci Res; 1986 Feb; 3(3):213-25. PubMed ID: 2871533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF somatostatin-like immunoreactivity in dementia.
    Beal MF; Growdon JH; Mazurek MF; Martin JB
    Neurology; 1986 Feb; 36(2):294-7. PubMed ID: 2868429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of DSIP- (delta sleep-inducing peptide) and P-DSIP-like (phosphorylated) immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type, multi-infarct syndrome, communicating hydrocephalus and Parkinson's disease.
    Ernst A; Cramer H; Strubel D; Kuntzmann F; Schoenenberger GA
    J Neurol; 1987 Oct; 235(1):16-21. PubMed ID: 2448424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
    Strittmatter M; Cramer H; Reuner C; Strubel D; Hamann G; Schimrigk K
    Biol Psychiatry; 1997 Jun; 41(11):1124-30. PubMed ID: 9146823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin-like immunoreactivity and acetylcholinesterase activities in cerebrospinal fluid of patients with Alzheimer disease and senile dementia of the Alzheimer type.
    Gomez S; Davous P; Rondot P; Faivre-Bauman A; Valade D; Puymirat J
    Psychoneuroendocrinology; 1986; 11(1):69-73. PubMed ID: 3517922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid somatostatin in delirium.
    Koponen H; Stenbäck U; Mattila E; Reinikainen K; Soininen H; Riekkinen PJ
    Psychol Med; 1989 Aug; 19(3):605-9. PubMed ID: 2572025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Crystal HA; Davies P
    J Neurochem; 1982 Jun; 38(6):1781-4. PubMed ID: 6176686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid levels of immunoreactive substance P and somatostatin in patients with multiple sclerosis and inflammatory CNS disease.
    Rösler N; Reuner C; Geiger J; Rissler K; Cramer H
    Peptides; 1990; 11(1):181-3. PubMed ID: 1692993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.
    Soininen HS; Jolkkonen JT; Reinikainen KJ; Halonen TO; Riekkinen PJ
    J Neurol Sci; 1984 Feb; 63(2):167-72. PubMed ID: 6142929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease.
    Cramer H; Rösler N; Rissler K; Gagnieu MC; Renaud B
    Neuropeptides; 1988 Oct; 12(3):119-24. PubMed ID: 2468107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical differences in the CSF between Binswanger's and Alzheimer's disease.
    Strittmatter M; Hamann GF; Grauer MT; Cramer H; Schimrigk K
    Dement Geriatr Cogn Disord; 1997; 8(1):34-42. PubMed ID: 8997550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance P-like immunoreactivity and somatostatin-like immunoreactivity in the ventricular fluid of patients with chronic pain syndromes.
    Jost S; Reuner C; Geiger J; Mohadjer M; Milios E; Cramer H
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):109-12. PubMed ID: 1834180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin-like immunoreactivity in lumbar cerebrospinal fluid from neurohistologically examined demented patients.
    Francis PT; Bowen DM; Neary D; Palo J; Wikstrom J; Olney J
    Neurobiol Aging; 1984; 5(3):183-6. PubMed ID: 6151122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low cerebrospinal fluid concentrations of peptide histidine valine and somatostatin-28 in Alzheimer's disease: altered processing of prepro-vasoactive intestinal peptide and prepro-somatostatin.
    Yasuda M; Maeda K; Kakigi T; Minamitani N; Kawaguchi T; Tanaka C
    Neuropeptides; 1995 Dec; 29(6):325-30. PubMed ID: 8837959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular fluid neuropeptides in Parkinson's disease. I. Levels and distribution of somatostatin-like immunoreactivity.
    Jost S; Reuner C; Mohadjer M; Mundinger F; Cramer H
    Neuropeptides; 1990 Apr; 15(4):219-25. PubMed ID: 1979661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cerebrospinal fluid somatostatin in neurologic disease.
    Beal MF; Mazurek MF; Black PM; Martin JB
    J Neurol Sci; 1985 Nov; 71(1):91-104. PubMed ID: 2868070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Davies P; Terry RD
    Neurobiol Aging; 1981; 2(1):9-14. PubMed ID: 6115327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease.
    Candy JM; Gascoigne AD; Biggins JA; Smith AI; Perry RH; Perry EK; McDermott JR; Edwardson JA
    J Neurol Sci; 1985 Dec; 71(2-3):315-23. PubMed ID: 2868073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.